No Data
12 Health Care Stocks Moving In Friday's Intraday Session
 Gainers Unity Biotechnology (NASDAQ:UBX) stock rose 68.8% to $1.44 during Friday's regular session. Trading volume for Unity Biotechnology's stock is 83.5 million as of 13:30 EST. This is 21114.4%
Terns, Rani top healthcare gainers; PLx Pharma, Co-Diagnostics lead losers' pack
Gainers: Terns Pharmaceuticals (TERN) +36%. Rani Therapeutics (RANI) +25%. AirSculpt Technologies (AIRS) +21%. Larimar Therapeutics (LRMR) +21%. Neptune Wellness (NEPT) +18%. Losers: PLx Pharma (PLX
Sientra (NASDAQ:SIEN) Stock Crosses Above Fifty Day Moving Average of $0.95
Sientra, Inc. (NASDAQ:SIEN – Get Rating)'s share price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.95 and traded as high as $
Sientra, Inc. CEO Ron Menezes on Q2 2022 Results -- Earnings Call Transcript >SIEN
From Seeking Alpha: Sientra, Inc. CEO Ron Menezes on Q2 2022 Results -- Earnings Call Transcript
Sientra Q2 EPS $(0.29) Up From $(0.32) YoY, Sales $21.51M Miss $23.75M Estimate
Sientra (NASDAQ:SIEN) reported quarterly losses of $(0.29) per share. This is a 9.38 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly s
Sientra Lowers FY22 Revenue Guidance From $93M-$97M To $90M-$95M Vs $95.19M Est.
Sientra Lowers FY22 Revenue Guidance From $93M-$97M To $90M-$95M Vs $95.19M Est.
Press Release: Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel
Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel SANTA BARBARA, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) ("Sientr
Press Release: Sientra Reports Second Quarter -2-
ad duration of the current economic headwinds, the Company's ability to recapture delayed procedures resulting from the COVID-19 pandemic, the positive reaction from plastic surgeons and their patient
Sientra 2Q Sales $21.5M >SIEN
Sientra 2Q Loss $18.3M >SIEN
Loading...